Literature DB >> 20185936

Penicillamine as a potent protector against injurious effects of cigarette smoke in aerodigestive tract cancer.

Rafael Nagler1, Shiri Cohen, Dana Savulescu, Svetlana Leschiner, Irina Otradnov, Moshe Gavish.   

Abstract

BACKGROUND: Cigarette smoke (CS) is the major risk factor for aerodigestive tract cancers such as lung and oral cancers.
METHODS: In in vitro models of lung and oral cancers, we found D-penicillamine (PenA) to be a most potent protector against CS, both in the absence and presence of saliva (a highly pro-oxidative condition).
RESULTS: The survival rate of lung cancer cells and oral cancer cells was reduced by CS in the absence of saliva by 39-45% (p < 0.01) and by 55-60% (p < 0.01) in the presence of saliva. The addition of 5 mM PenA to cell medium prior to CS exposure limited cell loss to 22-25% only (p < 0.01). Similarly, the iron chelator desferal protected the cells only in the presence of saliva. PenA also protected against a CS-induced increase in carbonyls (oxidized proteins) and decrease in p53 levels (in the presence of saliva) and mitochondrial membrane potential (a hallmark of CS-induced apoptotic cell death). Malfunctioning p53 often characterizes carcinogenesis of CS-induced cancers.
CONCLUSIONS: Redox-active iron and copper in pleural fluid and saliva, upon encounter with CS, may be responsible for this carcinogenesis, mediated via alteration of p53 function. Chelation of redox-active metals may be an efficient tool for prevention of CS-induced lung and oral cancers. The superiority of PenA results from its copper-chelating action as well as its antialdehyde and anti-inflammatory capabilities. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185936     DOI: 10.1159/000287967

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  1 in total

Review 1.  D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.

Authors:  Michela Pugliese; Vito Biondi; Enrico Gugliandolo; Patrizia Licata; Alessio Filippo Peritore; Rosalia Crupi; Annamaria Passantino
Journal:  Antibiotics (Basel)       Date:  2021-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.